Johnson & Johnson Innovation - JJDC Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 12
- Investments
- 403
- Portfolio
- 93
- Exits
- 178
Johnson & Johnson Innovation - JJDC General Information
Description
Founded in 1973, Johnson & Johnson Innovation-JJDC is the corporate venture capital arm of Johnson & Johnson based in New Brunswick, New Jersey. The firm seeks to invest in seed-level startups to series B and beyond companies operating in the pharmaceuticals, medical devices, and consumer healthcare sectors.
Contact Information
Website
www.jnjinnovation.com/jjdc
Formerly Known As
Johnson & Johnson Development Corporation
Year Founded
1973
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
- 410 George Street
- New Brunswick, NJ 08901
- United States
+1 (732) 000-0000
Johnson & Johnson Innovation - JJDC Investments & Acquisitions (403)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Rondo Therapeutics | 02-Mar-2022 | Early Stage VC | 0000 | Biotechnology | Generating Revenue | |
| 000000 000000 | 14-Jan-2022 | 00000 00000 | 00000 | Media and Information Services (B2B) | Generating Revenue | 00000 000000 00.0 |
| 000000000 000000 | 30-Dec-2021 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | |
| 000000000 | 02-Dec-2021 | 00000 00000 | 00000 | Drug Discovery | Startup | |
| 000 00000000000000 | 23-Nov-2021 | 00000 00000 | 000.00 | Biotechnology | Product Development | |
| 0000 000000 | 16-Nov-2021 | 00000 00000 | 0000 | Therapeutic Devices | Generating Revenue | 0000 00000 00.0 |
| 0000000 0000000000 | 10-Nov-2021 | 00000 | 0000 | Biotechnology | Startup | |
| 000000000 | 04-Nov-2021 | 000000000000 | 000.00 | Therapeutic Devices | Clinical Trials - General | 00000 00000 |
| Mauna Kea Technologies | 20-Sep-2021 | PIPE | 000.00 | Diagnostic Equipment | Generating Revenue/Not Profitable | |
| FlexDex | 24-Aug-2021 | Later Stage VC | 0000 | Surgical Devices | Generating Revenue | 0.00000 0000000000 00.0 |
Johnson & Johnson Innovation - JJDC Exits (178)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Syndesi Therapeutics | 01-Mar-2022 | Merger/Acquisition | 000 |
| 00000.00 | 08-Nov-2021 | 000000000000000000 | 00000 |
| 000000000 | 04-Nov-2021 | 000000000000000000 | 000.00 |
| 000000000 | 01-Nov-2021 | 000000000000000000 | 00000 |
| 0000000000 0000000 | 07-Oct-2021 | 000000000000000000 | |
| 000 000000 | 24-Sep-2021 | 000 | 00000 |
| 00 000000000000 | 24-Sep-2021 | 000 00 00000000 | |
| 00000 | 18-Aug-2021 | 000000000000000000 | 00.00 |
| CVRx | 30-Jun-2021 | IPO | 00000 |
| ImaCor | 25-Jun-2021 | Secondary Transaction - Private |
Johnson & Johnson Innovation - JJDC Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialJohnson & Johnson Innovation - JJDC Team (51)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Chris Picariello | President | New Brunswick, NJ | |||
| Fiona MacLaughlin Ph.D | Principal | 0 | 0 | London, United Kingdom | |
| Claire Leurent Ph.D | Principal, Venture Investments | Boston, MA | |||
| Wei Wu Ph.D | Principal, Venture Investments | 0 | 0 | 0 | San Francisco, CA |
| Anurag Mehta | Principal, Venure Investments | 0 | 0 | New York, NY |
Johnson & Johnson Innovation - JJDC Co-Investors (418)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| OrbiMed | 9 | 0 | 0 |
|
|
| Alexandria Venture Investments | 0 | 0 | 0 |
|
|
| Osage University Partners | 0 | 0 |
|
|
|
| Takeda Ventures | 0 | 0 |
|
|
|
| Novartis Venture Fund | 0 | 0 | 0 |
|
|